Amgen Launches AMGEVITA™ (Biosimilar Adalimumab) In Markets Across Europe
AMGEVITA is indicated for the treatment of active moderate-to-severe hidradenitis suppurativa (HS) (acne inversa) in adult patients with an …
Blog - Latest News
You are here: Home / Hidradenitis suppurativa / Amgen Launches AMGEVITA™ (Biosimilar Adalimumab) In Markets Across Eur...
Leave a Reply
Want to join the discussion?Feel free to contribute!